Quality of anticoagulation care in patients discharged from a pharmacist-managed anticoagulation clinic after stabilization of warfarin therapy

被引:28
作者
Garwood, Candice L. [1 ,2 ]
Dumo, Peter [2 ]
Baringhaus, Stephanie N. [1 ]
Laban, Kristyn M. [1 ]
机构
[1] Wayne State Univ, Eugene Applebaum Coll Pharm & Hlth Sci, Dept Pharm Practice, Detroit, MI 48201 USA
[2] Harper Univ Hosp, Detroit Med Ctr, Dept Pharm Adm, Detroit, MI USA
来源
PHARMACOTHERAPY | 2008年 / 28卷 / 01期
关键词
anticoagulant; warfarin; pharmacist; anticoagulation clinic; quality of anticoagulation;
D O I
10.1592/phco.28.1.20
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Study Objective. To determine if transitioning patients from a pharmacist-managed anticoagulation clinic after stabilization of warfarin therapy to physician-managed care alters the quality of anticoagulation care. Design. Retrospective medical record review. Setting. Pharmacist-managed, urban academic medical center-based outpatient anticoagulation clinic. Patients. Forty patients who were stabilized on warfarin therapy. Measurements and Main Results. Quality of anticoagulation care was measured by percentage of international normalized ratios (INRs) in target range, anticoagulation-related health care visits, and responses to satisfaction surveys. A significant decrease in anticoagulation control was observed on transition to physician-managed care. Before transition, 76% of all INRs were in target range versus 48% after transition (p<0.0001, chi(2) test). When performing paired analysis, a median 75% of each patient's INRs were therapeutic before transition compared with 36.5% after (p<0.0001, Wilcoxon signed rank test). Thirty-two percent of first INR values measured after transition from the clinic were in target range, and the median time to first follow-up INR was 41 days. The number of INR values above 4.5 and below 1.5 increased significantly after transition from the anticoagulation clinic (p<0.0001 and p=0.01, respectively, chi(2) test). Before transition from the anticoagulation clinic, two anticoagulation-related emergency department visits were - reported in one patient. After transition, 13 cases of additional medical care were reported among seven patients; seven of the 13 cases required an office visit with the physician, and six resulted in emergency room evaluation. None of these cases resulted in hospitalization. Patient satisfaction with clinical care provided by the anticoagulation clinic was significantly higher before transition. Conclusion. Transition of patients from a pharmacist-managed anticoagulation clinic back to physician-managed anticoagulation care after stabilization of warfarin therapy was associated with a significant decrease in INR control, increased medical care related to anticoagulation, and decreased patient satisfaction.
引用
收藏
页码:20 / 26
页数:7
相关论文
共 17 条
[1]  
American College of Chest Physicians, 2004, CHEST, V126, pS172
[2]  
Amruso Nadia A, 2004, J Am Pharm Assoc (2003), V44, P467, DOI 10.1331/1544345041475751
[3]   Comparison of an anticoagulation clinic with usual medical care -: Anticoagulation control, patient outcomes, and health care costs [J].
Chiquette, E ;
Amato, MG ;
Bussey, HI .
ARCHIVES OF INTERNAL MEDICINE, 1998, 158 (15) :1641-1647
[4]  
CORTELAZZO S, 1993, THROMB HAEMOSTASIS, V69, P316
[5]   To anticoagulate or not to anticoagulate? A common dilemma for the provider: Physicians' opinion poll based on a case study of an older long-term care facility resident with dementia and atrial fibrillation [J].
Dharmarajan, T. S. ;
Varma, Surendran ;
Akkaladevi, Shailaja ;
Lebelt, Anna S. ;
Norkus, Edward P. .
JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION, 2006, 7 (01) :23-28
[6]  
Ernst Michael E, 2003, J Am Pharm Assoc (2003), V43, P630, DOI 10.1331/154434503322452274
[7]   The increasing need for anticoagulant therapy to prevent stroke in patients with atrial fibrillation [J].
Ezekowitz, MD ;
Falk, RH .
MAYO CLINIC PROCEEDINGS, 2004, 79 (07) :904-913
[8]   RETROSPECTIVE EVALUATION OF A PHARMACIST-MANAGED WARFARIN ANTICOAGULATION CLINIC [J].
GARABEDIANRUFFALO, SM ;
GRAY, DR ;
SAX, MJ ;
RUFFALO, RL .
AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1985, 42 (02) :304-308
[9]   An analysis of the lowest effective intensity of prophylactic anticoagulation for patients with nonrheumatic atrial fibrillation [J].
Hylek, EM ;
Skates, SJ ;
Sheehan, MA ;
Singer, DE .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (08) :540-546
[10]  
Lewis S M, 1997, Manag Care Interface, V10, P66